Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N Engl J Med. 2007;356(3):213–5.
Jafari-Adli S, Jouyandeh Z, Qorbani M, Soroush A, Larijani B, Hasani-Ranjbar S. Prevalence of obesity and overweight in adults and children in Iran; a systematic review. J Diabetes Metab Disord. 2014;13(1):121.
Article PubMed PubMed Central Google Scholar
World Health Organization. Obesity and overweight: World Health Organization. 2006. https://www.who.int/news-room/fact-sheets/detail/obesity-andoverweight
Ahadi Z, Shafiee G, Qorbani M, Sajedinejad S, Kelishadi R, Arzaghi SM, et al. An overview on the successes, challenges and future perspective of a national school-based surveillance program: the CASPIAN study. J Diabetes Metab Disord. 2014;13(1):120.
Article PubMed PubMed Central Google Scholar
Angoorani P, Heshmat R, Ejtahed HS, Motlagh ME, Ziaodini H, Taheri M, et al. The association of parental obesity with physical activity and sedentary behaviors of their children: the CASPIAN-V study. J Pediatr (Versão em Português). 2018;94(4):410–8.
Ejtahed HS, Heshmat R, Motlagh ME, Hasani-Ranjbar S, Ziaodini H, Taheri M, et al. Association of parental obesity with cardiometabolic risk factors in their children: The CASPIAN-V study. J Clin Res Pediatr Endocrinol. 2018;13(4):e0193978.
Angoorani P, Heshmat R, Ejtahed H-S, Motlagh ME, Ziaodini H, Taheri M, et al. Validity of triglyceride–glucose index as an indicator for metabolic syndrome in children and adolescents: the CASPIAN-V study. Eating and weight disorders-studies on anorexia. Bulimia Obes. 2018;23(6):877–83.
Angoorani P, Khademian M, Ejtahed H-S, Heshmat R, Motlagh ME, Vafaeenia M, et al. Are non-high–density lipoprotein fractions associated with pediatric metabolic syndrome? The CASPIAN-V study. Lipids Health Dis. 2018;17(1):257.
Article CAS PubMed PubMed Central Google Scholar
Ejtahed HS, Kelishadi R, Qorbani M, Motlagh ME, Hasani‐Ranjbar S, Angoorani P, Beshtar S, Ziaodini H, Taheri M, Heshmat R. Utility of waist circumference‐to‐height ratio as a screening tool for generalized and central obesity among Iranian children and adolescents: The CASPIAN‐V study. Pediat Diab. 2019;20(5):530–7.
Heshmat R, Heidari M, Ejtahed H-S, Motlagh ME, Mahdavi-Gorab A, Ziaodini H, et al. Validity of a continuous metabolic syndrome score as an index for modeling metabolic syndrome in children and adolescents: the CASPIAN-V study. Diabetol Metab Syndr. 2017;9(1):89.
Article PubMed PubMed Central Google Scholar
Ejtahed H-S, Qorbani M, Motlagh ME, Angoorani P, Hasani-Ranjbar S, Ziaodini H, et al. Association of anthropometric indices with continuous metabolic syndrome in children and adolescents: the CASPIAN-V study. Eating and weight disorders-studies on anorexia. Bulimia Obes. 2018;23(5):597–604.
Payab M, Kelishadi R, Qorbani M, Motlagh ME, Hasani-Ranjbar S, Ejtahed HS, Ardalan G, Arefirad T, Asayesh H, Heshmat R. Association of healthy foods intake with anthropometric measures and blood pressure in a national sample of Iranian children and adolescents: the CASPIAN-IV Study. Minerva Pediat. 2016;71(5):420–30.
Payab M, Kelishadi R, Qorbani M, Motlagh ME, Ranjbar SH, Ardalan G, et al. Association of junk food consumption with high blood pressure and obesity in Iranian children and adolescents: the CASPIAN-IV Study. J Pediatr. 2015;91(2):196–205.
Zahedi H, Kelishadi R, Heshmat R, Hasani SR, Esmaeil MM, Ardalan G, et al. Association of adolescents’ weight status with life satisfaction: role of self, peers, family and school perception; the CASPIAN-IV Study. Minerva Pediatr. 2019;71(3):235–41.
Hasani-Ranjbar S, Shirzad N, Mashayekh Bakhshi F. A 3-year-old boy with severe obesity and pseudoacromegaly; short course treatment with Orlistat. Iran J Diabetes Lipid Disord. 2010;9:1–5.
Payab M, Hasani-Ranjbar S, Merati Y, Esteghamati A, Qorbani M, Hematabadi M, et al. The prevalence of metabolic syndrome and different obesity phenotype in Iranian male military personnel. Am J Men’s Health. 2017;11(2):404–13.
Ejtahed HS, Soroush MR, Hasani-Ranjbar S, Angoorani P, Mousavi B, Masumi M, et al. Prevalence of metabolic syndrome and health-related quality of life in war-related bilateral lower limb amputees. J Diabetes Metab Disord. 2017;16:17.
Article PubMed PubMed Central Google Scholar
Gholami M, Sharifi F, Shahriari S, Khoshnevisan K, Larijani B, Amoli MM. Association of interleukin-6 polymorphisms with obesity: A systematic review and meta-analysis. Cytokine. 2019;123:154769.
Article CAS PubMed Google Scholar
Hasani-Ranjbar S, Amoli MM, Tabatabaei-Malazy O, Rumi Y, Tavakkoly-Bazzaz J, Samimi H, et al. Effect of adiponectin gene polymorphisms on waist circumference in patients with diabetes. J Diabetes Metab Disord. 2012;11(1):14.
Article PubMed PubMed Central Google Scholar
Payab M, Amoli MM, Qorbani M, Hasani-Ranjbar S. Adiponectin gene variants and abdominal obesity in an Iranian population. Eati Weight Disord. 2017;22(1):85–90.
Tabatabaei-Malazy O, Hasani-Ranjbar S, Amoli MM, Heshmat R, Sajadi M, Derakhshan R, et al. Gender-specific differences in the association of adiponectin gene polymorphisms with body mass index. Rev Diabet Stud. 2010;7(3):241.
PubMed PubMed Central Google Scholar
Talaschian M, Amoli MM, Enayati S, Payab M, Hasani-Ranjbar S. Association between Trp48Arg polymorphism of the CD11c gene and risk for obesity among Iranian population. J Diabetes Metab Disord. 2018;17(2):197–201.
Article CAS PubMed PubMed Central Google Scholar
Payab M, Hasani-Ranjbar S, Aletaha A, Ghasemi N, Qorbani M, Atlasi R, et al. Efficacy, safety, and mechanisms of herbal medicines used in the treatment of obesity: A protocol for systematic review. Medicine. 2018;97(1):e8825.
Article PubMed PubMed Central Google Scholar
Hasani-Ranjbar S, Jouyandeh Z, Abdollahi M. A systematic review of anti-obesity medicinal plants-an update. J Diabetes Metab Disord. 2013;12(1):28.
Article PubMed PubMed Central Google Scholar
Hasani-Ranjbar S, Nayebi N, Larijani B, Abdollahi M. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J Gastroenterol. 2009;15(25):3073.
Article CAS PubMed PubMed Central Google Scholar
Namazi N, Larijani B, Ayati MH, Abdollahi M. The effects of Nigella sativa L. on obesity: A systematic review and meta-analysis. J Ethnopharmacol. 2018;219:173–81.
Article CAS PubMed Google Scholar
Kamali SH, Khalaj AR, Hasani-Ranjbar S, Esfehani MM, Kamalinejad M, Soheil O, et al. Efficacy of ‘Itrifal Saghir’, a combination of three medicinal plants in the treatment of obesity; A randomized controlled trial. Daru. 2012;20(1):33.
Article PubMed PubMed Central Google Scholar
Mousavi S, Milajerdi A, Sheikhi A, Kord-Varkaneh H, Feinle‐Bisset C, Larijani B, et al. Resveratrol supplementation significantly influences obesity measures: a systematic review and dose–response meta‐analysis of randomized controlled trials. Obes Rev. 2019;20(3):487–98.
Article CAS PubMed Google Scholar
Mousavi SM, Milajerdi A, Varkaneh HK, Gorjipour MM, Esmaillzadeh A. The effects of curcumin supplementation on body weight, body mass index and waist circumference: a systematic review and dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutri. 2020;60(1):171–80.
Tabatabaei-Malazy O, Shadman Z, Ejtahed H-S, Atlasi R, Abdollahi M, Larijani B. Quality of reporting of randomized controlled trials of herbal medicines conducted in metabolic disorders in Middle East countries: A systematic review. Complement Ther Med. 2018;38:61–6.
Mansouri M, Nayebi N, Hasani-Ranjbar S, Taheri E, Larijani B. The effect of 12 weeks Anethum graveolens (dill) on metabolic markers in patients with metabolic syndrome; a randomized double blind controlled trial. DARU J Pharm Sci. 2012;20(1):47.
Ejtahed HS, Soroush AR, Angoorani P, Larijani B, Hasani-Ranjbar S. Gut microbiota as a target in the pathogenesis of metabolic disorders: a new approach to novel therapeutic agents. Horm Metab Res. 2016;48(6):349-58.
Ejtahed HS, Angoorani P, Soroush AR, Siadat SD, Shirzad N, Hasani-Ranjbar S, Larijani B. Our little friends with big roles: alterations of the gut microbiota in thyroid disorders. Endocrine Metabolic & Immune Disorders-Drug Targets. 2020;20(3):344-50.
Aazami H, DehghanBanadaki H, Ejtahed HS, Fahimfar N, Razi F, Soroush AR, Hasani-Ranjbar S, Pasalar P, Badi SA, Siadat SD, Larijani B. The landscape of microbiota research in Iran; a bibliometric and network analysis. J Diab Metab Disord. 2020;1–5.
Ejtahed HS, Tabatabaei-Malazy O, Soroush AR, Hasani-Ranjbar S, Siadat SD, Raes J, et al. Worldwide trends in scientific publications on association of gut microbiota with obesity. Iran J Basic Med Sci. 2019;22(1):65–71.
PubMed PubMed Central Google Scholar
Ejtahed HS, Hasani-Ranjbar S. Neuromodulatory effect of microbiome on gut-brain axis; new target for obesity drugs. J Diabetes Metab Disord. 2019;18(1):263–5.
Article PubMed PubMed Central Google Scholar
Ejtahed HS, Hasani-Ranjbar S, Larijani B. Human microbiome as an approach to personalized medicine. Altern Ther Health Med. 2017;23(6):8–9.
Ejtahed H-S, Angoorani P, Hasani-Ranjbar S, Siadat S-D, Ghasemi N, Larijani B, et al. Adaptation of human gut microbiota to bariatric surgeries in morbidly obese patients: a systematic review. Microb Pathog. 2018;116:13–21.
Tabasi M, Ashrafian F, Khezerloo JK, Eshghjoo S, Behrouzi A, Javadinia SA, et al. Changes in gut microbiota and hormones after bariatric surgery: a bench-to-bedside review. Obes Surg. 2019;29(5):1663–74.
Ejtahed H-S, Soroush A-R, Siadat S-D, Hoseini-Tavassol Z, Larijani B, Hasani-Ranjbar S. Targeting obesity management through gut microbiota modulation by herbal products: A systematic review. Complement Ther Med. 2019;42:184–204.
留言 (0)